These differences may become extremely relevant when assessing the ability of wildtype and human disease associated variants to rescue iPLA2-VIA mutants and to determine how each variant gives rise to distinct pathogenesis in PLAN diseases. This evidence concerns the gene PLA2G6 and neurodegeneration with brain iron accumulation 2A.